Tarsa Therapeutics, Inc. announced it raised $1.25 Million in an initial filing from an offering of $1.25 Million

Jul 14, 2016•about 9 years ago

Amount Raised

$1.25 Million

Round Type

seed

PhiladelphiaBiotechnology

Company Information

Company

Tarsa Therapeutics, Inc.

Location

8 Penn Center, 1628 JFK Blvd Suite 1400

Philadelphia, Pennsylvania, United States

About

Tarsa Therapeutics develops an oral formulation of calcitonin for the treatment and prevention of postmenopausal osteoporosis.